Oncotarget

Research Papers:

Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network

Nardin Samuel, Gavin Wilson, Badr Id Said, Anna Pan, Genevieve Deblois, Nicholas W. Fischer, Roumiana Alexandrova, Guillermo Casallo, Tara Paton, Mathieu Lupien, Jean Gariepy, Daniele Merico, Thomas J. Hudson and David Malkin _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:49611-49622. https://doi.org/10.18632/oncotarget.10417

Metrics: PDF 1364 views  |   HTML 2337 views  |   ?  


Abstract

Nardin Samuel1,2,3, Gavin Wilson3,4, Badr Id Said2, Anna Pan2, Genevieve Deblois5, Nicholas W. Fischer6, Roumiana Alexandrova7, Guillermo Casallo7, Tara Paton7, Mathieu Lupien5, Jean Gariepy6, Daniele Merico7, Thomas J. Hudson1,3,4, David Malkin1,2,8

1Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Canada

2Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada

3Ontario Institute for Cancer Research, Toronto, Canada

4Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, Canada

5Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

6Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Canada

7The Centre for Applied Genomics (TCAG), Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada

8Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada

Correspondence to:

David Malkin, email: david.malkin@sickkids.ca

Keywords: miR-34A, p53, TP53, cell cycle, non-coding RNA

Received: April 07, 2016     Accepted: May 19, 2016     Published: July 06, 2016

ABSTRACT

microRNA-34A is a critical component of the p53 network and expression of miR- 34A is down-regulated by promoter hypermethylation or focal deletions in numerous human cancers. Although miR-34A deregulation may be an important driver in cancer, the endogenous role of this microRNA in cellular homeostasis is not well characterized. To address this knowledge gap, we aimed to determine the transcriptional landscape of the miR-34A-p53 axis in non-transformed cells. Using primary skin-derived fibroblast cell lines from patients who developed childhood cancers, and who harbor either germline TP53 mutations or are TP53 wild type, we sought to characterize the transcriptional response to miR-34A modulation. Through transcriptome-wide RNA-Sequencing, we show for the first time that in human non- transformed cells harboring TP53 mutations, miR-34A functions in a noncanonical manner to influence noncoding RNA networks, including RNA components of the minor (U12) spliceosome, as well as TP53-dependent and independent epigenetic pathways. miR- 34A-regulated transcripts include known cell cycle mediators and abrogation of miR-34A leads to a TP53-dependent increase in the fraction of cells in G2/M. Collectively, these results provide a framework for understanding the endogenous role of the miR-34A signaling axis and identify novel transcripts and pathways regulated by the essential miR-34A-p53 tumor suppressor network.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10417